Safety and Immunogenicity Study of the Western Equine Encephalitis (WEE) Vaccine

Western Equine Encephalitis Clinical Trial

Official title: Phase 2 Open-Label Safety and Immunogenicity Study of the Western Equine Encephalitis (WEE) Vaccine, Inactivated, Dried, TSI-GSD 210, Lot 3-1-92, in Healthy Adult Subjects at Risk of Exposure to Western Equine Encephalitis Virus

Status Recruiting

Clinical Trial Summary

This study is being conducted to collect safety and immunogenicity data for the WEE vaccine, TSI-GSD 210. Enrollment in this protocol is offered for personnel who enter areas where this virus is used in research or is endemic (an area where this disease process is found to occur frequently).

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Encephalitis
• Encephalomyelitis, Equine
• Western Equine Encephalitis

• NCT number: NCT02466750
• Study type: Interventional
• Source: U.S. Army Medical Research and Development Command
• Contact: Anthony Cardile, DO
• Phone: 310-619-8833
• Email: anthony.p.cardile.mil@mail.mil
• Status: Recruiting
• Phase: Phase 2
• Start date: December 15, 2015
• Completion date: December 2021